CONATUS PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
CONATUS PHARMACEUTICALS INC. - More news...
CONATUS PHARMACEUTICALS INC. - More news...
- Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 05-05-2020
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 09-11-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 08-30-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 07-11-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 07-03-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 04-18-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 04-15-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 04-02-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 03-13-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 01-30-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 01-29-2019
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 12-31-18
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 12-06-18
- Investor Expectations to Drive Momentum within 2U, Broadwind Energy, Nuverra Environmental Solutions, Ability, ContraFect, and Conatus Pharmaceuticals — Discovering Underlying Factors of Influence
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 09-20-18
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 08-24-18
-
Conatus Pharmaceuticals Inc. - CNAT Stock Chart Technical Analysis for 06-12-18
- Conatus Pharmaceuticals Inc. to Host Earnings Call
- Investor Network: Conatus Pharmaceuticals Inc. to Host Earnings Call
- Conatus Pharmaceuticals Promotes Daniel L. Ripley to Senior Vice President, Business Development, Program and Alliance Management
- Conatus Announces Exclusive Worldwide Option, Collaboration and License Agreement Covering Development and Commercialization of Emricasan
- Conatus Pharmaceuticals Announces Poster Presentations at AASLD Annual Meeting
- Conatus Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
- Conatus Pharmaceuticals Reports Third Quarter 2016 Financial Results and Program Updates
- Conatus Initiates Phase 2b ENCORE-PH Clinical Trial of Emricasan in Patients with NASH Cirrhosis
- Conatus Pharmaceuticals to Report Third Quarter 2016 Financial Results
- Conatus Pharmaceuticals Announces Acceptance of Emricasan Abstracts for AASLD Annual Meeting
- Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH
